InvestorsHub Logo

Dieselpro

03/04/21 10:51 PM

#150062 RE: crazyjogger925 #150061

Keytruda another immunotherapy did $3.7 billion in one quarter. And that's with a limited patient population. Leronlimab's basket trial covers over 20 cancers.